vs

Side-by-side financial comparison of FRIEDMAN INDUSTRIES INC (FRD) and Inspire Medical Systems, Inc. (INSP). Click either name above to swap in a different company.

Inspire Medical Systems, Inc. is the larger business by last-quarter revenue ($204.6M vs $168.0M, roughly 1.2× FRIEDMAN INDUSTRIES INC). On growth, FRIEDMAN INDUSTRIES INC posted the faster year-over-year revenue change (78.6% vs 1.6%). Over the past eight quarters, FRIEDMAN INDUSTRIES INC's revenue compounded faster (13.3% CAGR vs 2.2%).

Hellman & Friedman (H&F) is an American private equity firm founded in 1984 by Warren Hellman and Tully Friedman that makes investments primarily through leveraged buyouts as well as growth capital investments. It has focused its efforts on several core target industries including media, financial services, professional services and information services.

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

FRD vs INSP — Head-to-Head

Bigger by revenue
INSP
INSP
1.2× larger
INSP
$204.6M
$168.0M
FRD
Growing faster (revenue YoY)
FRD
FRD
+76.9% gap
FRD
78.6%
1.6%
INSP
Faster 2-yr revenue CAGR
FRD
FRD
Annualised
FRD
13.3%
2.2%
INSP

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
FRD
FRD
INSP
INSP
Revenue
$168.0M
$204.6M
Net Profit
$3.0M
Gross Margin
2.3%
86.5%
Operating Margin
2.3%
13.0%
Net Margin
1.8%
Revenue YoY
78.6%
1.6%
Net Profit YoY
364.1%
EPS (diluted)
$0.43
$-0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRD
FRD
INSP
INSP
Q1 26
$204.6M
Q4 25
$168.0M
$269.1M
Q3 25
$152.4M
$224.5M
Q2 25
$134.8M
$217.1M
Q1 25
$201.3M
Q4 24
$94.1M
$239.7M
Q3 24
$106.8M
$203.2M
Q2 24
$114.6M
$195.9M
Net Profit
FRD
FRD
INSP
INSP
Q1 26
Q4 25
$3.0M
$136.1M
Q3 25
$2.2M
$9.9M
Q2 25
$5.0M
$-3.6M
Q1 25
$3.0M
Q4 24
$-1.2M
$35.2M
Q3 24
$-675.0K
$18.5M
Q2 24
$2.6M
$9.8M
Gross Margin
FRD
FRD
INSP
INSP
Q1 26
86.5%
Q4 25
2.3%
86.6%
Q3 25
1.9%
85.8%
Q2 25
5.2%
84.0%
Q1 25
84.7%
Q4 24
85.0%
Q3 24
-0.2%
84.1%
Q2 24
-1.2%
84.8%
Operating Margin
FRD
FRD
INSP
INSP
Q1 26
13.0%
Q4 25
2.3%
17.1%
Q3 25
1.9%
4.3%
Q2 25
5.2%
-1.5%
Q1 25
-0.7%
Q4 24
-1.3%
13.3%
Q3 24
-0.2%
7.0%
Q2 24
-1.2%
2.6%
Net Margin
FRD
FRD
INSP
INSP
Q1 26
Q4 25
1.8%
50.6%
Q3 25
1.5%
4.4%
Q2 25
3.7%
-1.7%
Q1 25
1.5%
Q4 24
-1.2%
14.7%
Q3 24
-0.6%
9.1%
Q2 24
2.2%
5.0%
EPS (diluted)
FRD
FRD
INSP
INSP
Q1 26
$-0.39
Q4 25
$0.43
$4.57
Q3 25
$0.32
$0.34
Q2 25
$0.71
$-0.12
Q1 25
$0.10
Q4 24
$-0.17
$1.17
Q3 24
$-0.10
$0.60
Q2 24
$0.37
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRD
FRD
INSP
INSP
Cash + ST InvestmentsLiquidity on hand
$3.0M
$98.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$142.2M
$792.3M
Total Assets
$311.9M
$911.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRD
FRD
INSP
INSP
Q1 26
$98.9M
Q4 25
$3.0M
$308.3M
Q3 25
$4.6M
$322.6M
Q2 25
$2.1M
$300.9M
Q1 25
$369.2M
Q4 24
$1.1M
$445.5M
Q3 24
$2.5M
$411.0M
Q2 24
$4.1M
$439.7M
Stockholders' Equity
FRD
FRD
INSP
INSP
Q1 26
$792.3M
Q4 25
$142.2M
$781.2M
Q3 25
$139.3M
$666.5M
Q2 25
$137.3M
$677.8M
Q1 25
$635.7M
Q4 24
$127.3M
$689.7M
Q3 24
$128.8M
$696.6M
Q2 24
$129.7M
$638.1M
Total Assets
FRD
FRD
INSP
INSP
Q1 26
$911.4M
Q4 25
$311.9M
$907.3M
Q3 25
$311.3M
$807.7M
Q2 25
$219.1M
$802.2M
Q1 25
$730.8M
Q4 24
$210.3M
$808.4M
Q3 24
$209.2M
$796.2M
Q2 24
$222.8M
$728.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRD
FRD
INSP
INSP
Operating Cash FlowLast quarter
$-4.7M
Free Cash FlowOCF − Capex
$-6.3M
FCF MarginFCF / Revenue
-3.8%
Capex IntensityCapex / Revenue
1.0%
Cash ConversionOCF / Net Profit
-1.56×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRD
FRD
INSP
INSP
Q1 26
Q4 25
$-4.7M
$52.5M
Q3 25
$434.0K
$68.5M
Q2 25
$15.5M
$2.7M
Q1 25
$-6.7M
Q4 24
$69.2M
Q3 24
$52.3M
Q2 24
$-6.1M
$-78.0K
Free Cash Flow
FRD
FRD
INSP
INSP
Q1 26
Q4 25
$-6.3M
$41.8M
Q3 25
$-2.0M
$58.1M
Q2 25
$13.7M
$-6.3M
Q1 25
$-15.1M
Q4 24
$62.2M
Q3 24
$44.3M
Q2 24
$-7.1M
$-12.5M
FCF Margin
FRD
FRD
INSP
INSP
Q1 26
Q4 25
-3.8%
15.5%
Q3 25
-1.3%
25.9%
Q2 25
10.2%
-2.9%
Q1 25
-7.5%
Q4 24
25.9%
Q3 24
21.8%
Q2 24
-6.2%
-6.4%
Capex Intensity
FRD
FRD
INSP
INSP
Q1 26
Q4 25
1.0%
4.0%
Q3 25
1.6%
4.6%
Q2 25
1.3%
4.1%
Q1 25
4.2%
Q4 24
2.9%
Q3 24
3.9%
Q2 24
0.9%
6.3%
Cash Conversion
FRD
FRD
INSP
INSP
Q1 26
Q4 25
-1.56×
0.39×
Q3 25
0.19×
6.90×
Q2 25
3.08×
Q1 25
-2.24×
Q4 24
1.96×
Q3 24
2.83×
Q2 24
-2.36×
-0.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FRD
FRD

Prime Coil$152.0M90%
Manufactured Pipe$14.9M9%
Customer Owned$1.1M1%

INSP
INSP

Segment breakdown not available.

Related Comparisons